Who invested in Centauri Therapeutics?
Centauri Therapeutics's investors include Innovate UK, Novo Holdings and Boehringer Ingelheim Venture Fund.
United Kingdom · Series A startup
4 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised 9 months ago
Funding summaryUpdated 26 Oct 2026
$39Mraised across 4 rounds since 2022, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Centauri Therapeutics's investors include Innovate UK, Novo Holdings and Boehringer Ingelheim Venture Fund.
Centauri Therapeutics has raised $39M across 4 rounds since 2022.
Centauri Therapeutics's most recent round was a Series A of $8.1M in Feb 2026.
Centauri Therapeutics's largest round on record is $12M (Series A), in Jul 2023.
Centauri Therapeutics's first round on record, in Feb 2026, was backed by Innovate UK, Novo Holdings and Boehringer Ingelheim Venture Fund.
Centauri Therapeutics's latest named round is a Series A, in Feb 2026.
Centauri Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.